Scarica l'app Stockscreener
36.76
1.88%
0.68
Pre-mercato:
37.14
0.38
+1.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$36.08
Aprire:
$34.88
Volume 24 ore:
1.46M
Relative Volume:
0.62
Capitalizzazione di mercato:
$5.60B
Reddito:
$3.44B
Utile/perdita netta:
$-8.30M
Rapporto P/E:
-247.21
EPS:
-0.1487
Flusso di cassa netto:
$43.30M
1 W Prestazione:
+4.02%
1M Prestazione:
-7.66%
6M Prestazione:
+5.54%
1 anno Prestazione:
-10.67%
Intervallo 1D:
$34.77
$37.61
Intervallo di 1 settimana:
$33.11
$37.61
Portata 52W:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Nome
Bruker Corp
Settore
Industria
Telefono
978663-3660
Indirizzo
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
36.76 | 5.60B | 3.44B | -8.30M | 43.30M | -0.1487 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-10 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Iniziato | Goldman | Sell |
| 2025-11-20 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-10 | Iniziato | UBS | Neutral |
| 2024-12-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-10-15 | Iniziato | Barclays | Overweight |
| 2024-09-30 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-02-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2022-10-21 | Iniziato | UBS | Buy |
| 2022-08-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Iniziato | Goldman | Sell |
| 2020-11-16 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Downgrade | Needham | Strong Buy → Hold |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-06-24 | Reiterato | Needham | Strong Buy |
| 2019-06-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
| 2019-05-06 | Reiterato | Needham | Strong Buy |
| 2019-05-03 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Aggiornamento | UBS | Sell → Neutral |
| 2019-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Reiterato | BTIG Research | Buy |
| 2019-01-03 | Iniziato | Needham | Strong Buy |
Mostra tutto
Bruker Corp Borsa (BRKR) Ultime notizie
BRKR SEC FilingsBruker Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Bruker Corporation (BRKR) stock price, news, quote and history - Yahoo Finance UK
Should You Continue to Retain Bruker Stock in Your Portfolio? - Yahoo Finance
SG Americas Securities LLC Grows Holdings in Bruker Corporation $BRKR - MarketBeat
Context Capital Management, LLC's Bruker Corp(BRKRP.PFD) Holding History - GuruFocus
How The Bruker (BRKR) Story Is Shifting As Growth Hopes Meet Margin And Helium Risks - Yahoo Finance
Bruker appoints QIAGEN CEO Thierry Bernard to board of directors - Investing.com
Thierry L. Bernard appointed to Bruker board as QIAGEN CEO set to step down - TradingView
Thierry Bernard joins Bruker (NASDAQ: BRKR) Board as new director - Stock Titan
Bruker Announces Appointment of Thierry Bernard to its Board of Directors - Financial Times
BRKR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Bruker, Seer Each Claim Partial Win in US Patent Board Ruling - 富途牛牛
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating - Moomoo
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker Corp (BRKR) Shares Up 3.62% on Mar 30 - GuruFocus
Bruker Corp (BRKR) Stock Price Quote Today & Current Price Chart - Capital.com
Bruker Corp (BRKR) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Guggenheim Lowers Bruker (BRKR) Price Target to $50 with Maintai - GuruFocus
Bruker (BRKR) Subsidiaries Impacted by Patent Trial Outcome - GuruFocus
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries - Yahoo Finance
JPMorgan Chase & Co. Trims Stock Position in Bruker Corporation $BRKR - MarketBeat
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares in Bruker (NYSE: BRKR) - Stock Titan
Bruker introduces analytical and automation innovations at analytica 2026 - SelectScience
Bruker (BRKR) Stock Is Up, What You Need To Know - Yahoo Finance
Here’s Why Bruker’s (BRKR) Positive Momentum Returned in Q4 - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Declares Quarterly Dividend of $0.05 - MarketBeat
Assessing Bruker (BRKR) Valuation After Steep Multi‑Period Share Price Declines - Yahoo Finance
Will Bruker (BRKR) be Able to Rebound? - Insider Monkey
Bruker (NASDAQ: BRKR) EVP Mark Munch exercises options and sells 2,000 shares - Stock Titan
Bruker Corporation $BRKR Shares Purchased by Aquatic Capital Management LLC - MarketBeat
Bruker Corp Stock (ISIN: US1167941087) Faces Rising Short Interest Amid Investor Scrutiny - AD HOC NEWS
Callodine Capital Management LP Makes New $1.11 Million Investment in Bruker Corporation $BRKR - MarketBeat
Mark R Munch reports multiple share sales (BRKR) under Rule 144 - Stock Titan
Bruker Corp (BRKR) Trading Down 3.62% on Mar 13 - GuruFocus
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics and Performance Challenges - Markets Mojo
Bruker Makes Acquisitions; LeddarTech Added to Nasdaq: Week in Brief: 1/5/24 - Photonics Spectra
Natixis Advisors LLC Boosts Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Position Increased by Ceredex Value Advisors LLC - MarketBeat
Is Bruker (BRKR) Quietly Recasting Its Competitive Moat With Spatial Biology And Proteomics Upgrades? - simplywall.st
These analysts cut their forecasts on Bruker following Q4 results - MSN
Citigroup Inc. Sells 29,083 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Shares Acquired by Rhenman & Partners Asset Management AB - MarketBeat
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know - Finviz
RSI Alert: Bruker (BRKR) Now Oversold - Nasdaq
Orbis group reports 16.13M shares in Bruker (BRKR) as 10.6% ownership - Stock Titan
Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers - Yahoo Finance
Bruker Corp To Go Ex-Dividend On March 23rd, 2026 With 0.05 USD Dividend Per Share - 富途牛牛
BRKRP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bruker Corp Azioni (BRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):